Financial Enhancement Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.92M | Buy |
|
|||||
|
2025
Q2 | $1.74M | Sell |
|
|||||
|
2025
Q1 | $1.82M | Buy |
|
|||||
|
2024
Q4 | $1.7M | Buy |
|
|||||
|
2024
Q3 | $813K | Sell |
|
|||||
|
2024
Q2 | $1.92M | Buy |
|
|||||
|
2024
Q1 | $1.41M | Buy |
|
|||||
|
2023
Q4 | $1.17M | Hold |
|
|||||
|
2023
Q3 | $1.15M | Hold |
|
|||||
|
2023
Q2 | $846K | Hold |
|
|||||
|
2023
Q1 | $813K | Buy |
|
|||||
|
2022
Q4 | $622K | Sell |
|
|||||
|
2022
Q3 | $631K | Hold |
|
|||||
|
2022
Q2 | $633K | Hold |
|
|||||
|
2022
Q1 | $559K | Sell |
|
|||||
|
2021
Q4 | $655K | Buy |
|
|||||
|
2021
Q3 | $535K | Sell |
|
|||||
|
2021
Q2 | $554K | Hold |
|
|||||
|
2021
Q1 | $451K | Buy |
|
|||||
|
2020
Q4 | $377K | Buy |
|
|||||
|
2020
Q3 | $277K | Buy |
|
|||||
|
2020
Q2 | $301K | Buy |
|
|||||
|
2020
Q1 | $203K | Hold |
|
|||||
|
2019
Q4 | $193K | Hold |
|
|||||
|
2019
Q3 | $164K | Buy |
|
|||||
|
2019
Q2 | $148K | Hold |
|
|||||
|
2019
Q1 | $174K | Hold |
|
|||||
|
2018
Q4 | $144K | Hold |
|
|||||
|
2018
Q3 | $144K | Hold |
|
|||||
|
2018
Q2 | $114K | Sell |
|
|||||
|
2018
Q1 | $120K | Buy |
|